Mandate

Vinge advises KEYTO Group in connection with the acquisition of Hemfixarna

KEYTO Group continues its growth journey by strengthening its offering in Sweden as Hemfixarna Nordic AB joins KEYTO Group.

Vinges team mainly consisted of Jonas Bergström, Gustav Wahlberg and Ian Linde (M&A), William Karo Persson (Employment), Ian Jonsson and Filippa Eriksson (IP), Hedvig Ekdahl and Avidh Tajik (Commercial Agreements), Elis Allmark and Katja Häglund (IT & GDPR) as well as Filippa Bergkvist (Transaction Support).

Read the clients press release here.

Related

Vinge has advised Course Corrected VC on the establishment of Course Corrected VC Fund II

Vinge has advised Course Corrected VC on the establishment and structuring of their second fund, Course Corrected VC Fund II (the “Fund”).
November 12, 2026

Vinge advises Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun

Vinge is advising Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun from Dalafast. The acquisition comprises four properties with a total of 23,200 square metres of retail space, which together constitute Tallen’s largest retail area.
November 11, 2026

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026